Comparison between Astec LifeSciences IPO and Euro Multivision IPO.
Astec LifeSciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Euro Multivision IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Astec LifeSciences IPO is up to ₹61.50 Cr whereas the issue size of the Euro Multivision IPO is up to ₹66.00 Cr. The final issue price of Astec LifeSciences IPO is ₹82.00 per share and of Euro Multivision IPO is ₹75.00 per share.
| Astec LifeSciences IPO | Euro Multivision IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹77.00 per share | ₹70.00 per share |
| Issue Price (Upper) | ₹82.00 per share | ₹75.00 per share |
| Issue Price (Final) | ₹82.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 75 shares | 90 shares |
| Fresh Issue Size | 75,00,150 shares | 88,00,049 shares |
| Fresh Issue Size (Amount) | up to ₹61.50 Cr | up to ₹66.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 75,00,150 shares | 88,00,049 shares |
| Issue Size Total (Amount) | up to ₹61.50 Cr | up to ₹66.00 Cr |
Astec LifeSciences IPO opens on Oct 29, 2009, while Euro Multivision IPO opens on Sep 22, 2009. The closing date of Astec LifeSciences IPO and Euro Multivision IPO is Nov 04, 2009, and Sep 24, 2009, respectively.
| Astec LifeSciences IPO | Euro Multivision IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 29, 2009 | Sep 22, 2009 |
| Issue Close | Nov 04, 2009 | Sep 24, 2009 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Nov 25, 2009 | Oct 15, 2009 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Astec LifeSciences IPO P/E ratio is , as compared to Euro Multivision IPO P/E ratio of .
| Astec LifeSciences IPO | Euro Multivision IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 0.9999 | 81.11 | ||||
| Promoter Shareholding (Post-Issue) | 55.69 | 51.12 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹138.82 Cr. | ₹178.50 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 35.15 | 5.83 |
In the Astec LifeSciences IPO Retail Individual Investors (RII) are offered 25,90,000 shares while in Euro Multivision IPO retail investors are offered 25,90,000 shares. Qualified Institutional Buyers (QIB) are offered 37,00,000 shares in Astec LifeSciences IPO and 43,00,000 shares in Euro Multivision IPO.
| Astec LifeSciences IPO | Euro Multivision IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 37,00,000 shares | 43,00,000 shares |
| NII | 11,10,000 shares | 12,90,000 shares |
| RII | 25,90,000 shares | 30,10,000 shares |
| Employee | 1,00,000 shares | 2,00,000 shares |
| Others | ||
| Total | 75,00,000 shares | 88,00,000 shares |
Astec LifeSciences IPO subscribed 1.56x in total, whereas Euro Multivision IPO subscribed 1.81x.
| Astec LifeSciences IPO | Euro Multivision IPO | |
|---|---|---|
| QIB (times) | 0.61x | 1.23x |
| NII (times) | 3.00x | 3.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.36x | 1.89x |
| Employee (times) | 0.50x | 0.31x |
| Other (times) | ||
| Total (times) | 1.56x | 1.81x |
